Literature DB >> 24272056

Correlation between active rosette formation and delayed cutaneous hypersensitivity in experimental allergic encephalomyelitis.

D H Lee1, G A Hashim, J C Pierce.   

Abstract

The effect of encephalitogenic myelin basic protein, BP, on active rosette-forming T cells (ARFC) was compared to that of nonencephalitogenic peptide S42, a synthetic analogue of the tryptophan region of BP. Depression of ARFC by these antigens was reversible within 24 h after a second dose of the antigen into the skin, or after in vitro incubation of lymphocytes with the sensitizing antigen (Ag-ARFC). The ratio of Ag-ARFC to ARFC rose with time following the sensitization but fell shortly before the clinical onset of experimental allergic encephalomyelitis in animals sensitized with BP. In contrast, the Ag-ARFC/ARFC ratios for animals sensitized with peptide S42 reached plateau levels from which they did not drop. The kinetics of the Ag-ARFC/ARFC responses paralleled those for delayed-type skin hypersensitivity (DTH) in the respective animals. The DTH responses rose following sensitization and fell shortly after the appearance of clinical signs of EAE. The results of this study provide in vitro and in vivo evidence for sensitization to myelin basic protein, and focus attention on the ARFC as a measure for an immunologically active cell population which may be quantitated by antigenic stimulation.

Entities:  

Year:  1977        PMID: 24272056     DOI: 10.1007/BF00969359

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  18 in total

1.  T rosettes in alcoholic cirrhosis of the liver.

Authors:  M R Berenyi; B Straus; L Avila
Journal:  JAMA       Date:  1975-04-07       Impact factor: 56.272

2.  Suppression of T-lymphocyte rosettes by rifampin. Studies in normals and patients with tuberculosis.

Authors:  S Gupta; M H Grieco; I Siegel
Journal:  Ann Intern Med       Date:  1975-04       Impact factor: 25.391

3.  Editorial: T-rosette forming cells, cellular immunity and cancer.

Authors:  H H Fudenberg; J Wybran; D Robbins
Journal:  N Engl J Med       Date:  1975-02-27       Impact factor: 91.245

4.  Antigen-stimulated rosette formation by T lymphocytes in experimental allergic encephalomyelitis.

Authors:  G A Hashim; D H Lee; J C Pierce
Journal:  Neurochem Res       Date:  1977-02       Impact factor: 3.996

5.  Rosette-forming cells, immunologic deficiency diseases and transfer factor.

Authors:  J Wybran; A S Levin; L E Spitler; H H Fudenberg
Journal:  N Engl J Med       Date:  1973-04-05       Impact factor: 91.245

6.  Lymphocyte characteristics in rheumatic patients and the effect of azathioprine therapy.

Authors:  D T Yy; P J Clements; J B Peter; J Levy; H E Paulus; E V Barnett
Journal:  Arthritis Rheum       Date:  1974 Jan-Feb

7.  Rosette formation, a test for cellular immunity.

Authors:  J Wybran; H H Fudenberg
Journal:  Trans Assoc Am Physicians       Date:  1971

8.  Human lymphocyte subpopulation: early and late rosettes.

Authors:  D T Yu
Journal:  J Immunol       Date:  1975-07       Impact factor: 5.422

9.  Altered distribution of lesions after repeated passive transfers of allergic encephalomyelitis.

Authors:  S Levine; E M Hoenig; E J Wenk
Journal:  Proc Soc Exp Biol Med       Date:  1967-11

10.  The human rosette-forming cell as a marker of a population of thymus-derived cells.

Authors:  J Wybran; M C Carr; H H Fudenberg
Journal:  J Clin Invest       Date:  1972-10       Impact factor: 14.808

View more
  2 in total

1.  The enhancing effect of multiple sclerosis brain homogenates on the active E rosette forming lymphocytes.

Authors:  H Offner; S C Rastogi; G Konat; J Calusen
Journal:  J Neurol       Date:  1978-08-25       Impact factor: 4.849

2.  Myelin basic protein-stimulated rosette-forming T cells in multiple sclerosis.

Authors:  G A Hashim; D H Lee; J C Pierce; C W Braun
Journal:  Neurochem Res       Date:  1978-02       Impact factor: 3.996

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.